139 Scientists at the Carver College of Medicine at the University of Iowa in the US have found that high doses of vitamin C, in addition to intravenous chemotherapy, increase the survival of people with metastatic pancreatic cancer.
According to Army , the results of the study were published in the journal Redox Biology.
In the study, researchers administered high-dose intravenous vitamin C of 75 grams three times a week to patients with metastatic pancreatic cancer in addition to standard chemotherapy. As a result, the patients’ life expectancy doubled – from eight to sixteen months.
The experiment also showed a positive effect on the period of disease progression, which increased from four to six months. Patients who received vitamin C tolerated the treatment better and reported fewer side effects than those who received chemotherapy alone.
Professor Joseph Cullen, a leading researcher in the Department of Surgical and Radiation Oncology at the University of Iowa, noted that these impressive results are the result of two decades of research into the properties of vitamin C in the fight against cancer cells. Scientists emphasize that vitamin C is inexpensive. Its use in high doses with chemotherapy could become a new standard for patients with advanced pancreatic cancer.
